protein
ubiquitin
import
posttransl
modif
regul
varieti
cellular
biolog
process
ie
signal
transduct
protein
turnov
cell
cycl
progress
immun
inflammatori
respons
etc
modif
howev
often
revers
deubiquitinas
dub
remov
variou
ubiquitin
molecul
substrat
surprisingli
mani
dna
rna
virus
evolv
encod
dub
manipul
divers
cellular
pathway
current
discov
viral
dub
larg
resembl
cellular
counterpart
structur
gener
fall
two
major
class
ubiquitinspecif
proteas
usp
eg
coronavirus
herpesvirus
picornavirus
etc
ovarian
tumor
proteas
otu
eg
arterivirus
nairovirus
tymovirus
function
viral
dub
demonstr
exhibit
immun
suppress
activ
vitro
neg
regul
host
innat
immun
interferon
signal
product
proinflammatori
cytokin
chemokin
although
biolog
signific
viru
infect
remain
determin
mani
report
concern
deubiquitinas
porcin
reproduct
respiratori
syndrom
viru
prrsv
positivestrand
rna
viru
famili
arterivirida
order
nidoviral
major
pathogen
swine
caus
coloss
annual
econom
loss
worldwid
swine
industri
prrsv
deubiquitinas
specifi
papainlik
proteas
domain
locat
within
nterminu
nonstructur
protein
multidomain
multifunct
replicas
protein
viru
life
cycl
phylogenet
prrsv
belong
newli
identifi
otu
superfamili
repres
novel
class
cystein
proteas
put
catalyt
site
figur
highli
conserv
among
arterivirus
also
among
otu
famili
member
core
domain
prrsv
size
amino
acid
aa
base
sequenc
align
equin
arter
viru
eav
otu
famili
member
differ
eav
downstream
flank
sequenc
aa
prrsv
core
figur
howev
requir
proteas
activ
earlier
biochem
studi
demonstr
prrsv
possess
ci
transcleavag
activ
mediat
proteolyt
cleavag
junction
moreov
two
activ
decoupl
point
mutat
residu
mutat
select
block
tran
ciscleavag
activ
consequ
mutat
lethal
prrsv
recent
prrsv
shown
possess
deubiquitin
activ
transfect
ft
cell
antagon
interferon
signal
inhibit
activ
featur
similar
counterpart
eav
nairovirus
famili
bunyavirida
deaton
et
al
report
dub
activ
prrsv
vitro
assay
found
e
coli
purifi
recombin
aa
abl
cleav
polyubiquitin
chain
vitro
hand
although
prrsv
shown
deisgyl
activ
transfect
human
cell
recombin
show
littl
vitro
deisgyl
activ
toward
porcin
origin
leav
question
whether
actual
effici
cleav
swine
conjug
primari
macrophag
case
clear
prrsv
possess
least
ci
transcleavag
dub
activ
howev
biochem
properti
contribut
viral
infect
remain
poorli
defin
studi
start
character
dub
activ
hpprrsv
strain
use
vitro
cellbas
assay
use
sitedirect
mutagenesi
abl
identifi
mutat
differenti
dub
activ
ci
transcleavag
activ
assess
role
context
prrsv
infect
revers
genet
analysi
result
reveal
novel
biochem
aspect
prrsv
show
dub
activ
ciscleavag
activ
like
import
prrsv
replic
unexpectedli
also
reveal
strong
link
prrsv
virusinduc
inflamm
occur
dubindepend
manner
find
advanc
understand
prrsv
function
regul
host
immun
implic
antivir
drug
vaccin
develop
hek
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
carlsbad
ca
usa
fb
invitrogen
ca
usa
primari
porcin
pulmonari
alveolar
macrophag
pam
obtain
specificpathogenfre
spf
pig
previous
describ
cultur
medium
invitrogen
ca
usa
contain
fetal
bovin
serum
fb
invitrogen
ca
usa
chines
highli
pathogen
prrsv
strain
infecti
cdna
clone
describ
previous
mous
antiflag
monoclon
antibodi
mous
antiha
monoclon
antibodi
mous
monoclon
antibodi
rabbit
antimyc
polyclon
antibodi
purchas
sigmaaldrich
st
loui
mo
usa
horseradish
peroxidas
hrp
conjug
goat
antimous
polyclon
antibodi
hrpconjug
goat
antirabbit
polyclon
antibodi
purchas
zsgbbio
beij
china
restrict
enzym
use
studi
new
england
biolab
inc
beverli
usa
prokaryot
express
plasmid
express
strepii
strep
ii
construct
clone
respect
region
code
aa
aa
hpprrsv
strain
access
number
vector
novagen
madison
wi
usa
site
nco
xho
strep
ii
tag
attach
cterminu
purif
purpos
mammalian
plasmid
express
myc
made
clone
sequenc
vector
clonetech
ca
usa
site
bamh
xho
frame
cmyc
epitop
tag
code
sequenc
plasmid
gener
fusion
express
indic
epitop
tag
correspond
code
region
lack
first
amino
acid
vector
clonetech
mountain
view
ca
usa
site
bgl
ii
bamh
gene
creat
eukaryot
plasmid
control
cmv
promot
kozak
core
sequenc
also
includ
allow
optim
express
express
deriv
point
mutat
mutant
creat
quikchang
sitedirect
mutagenesi
construct
gener
standard
recombin
dna
procedur
verifi
dna
sequenc
bacteri
strain
contain
plasmid
strepii
deriv
cultur
overnight
inocul
ml
yeast
extracttrypton
medium
cultur
bacteri
densiti
nm
reach
protein
express
induc
h
addit
iptg
sigma
final
concentr
mm
cell
harvest
centrifug
rpm
min
resuspend
pb
proteas
inhibitor
cocktail
sigma
cell
sonic
lyse
min
ice
triton
sigma
cell
lysat
clear
centrifug
min
supernat
incub
ul
streptactin
sepharos
ge
healthcar
overnight
rocker
streptactin
sepharos
bead
collect
centrifug
wash
six
time
tri
buffer
mm
tri
ph
target
protein
elut
ul
elut
buffer
mm
tri
mm
desthiobiotin
glycerol
ph
dub
activ
purifi
prrsv
assay
reaction
contain
indic
amount
purifi
protein
ubamc
boston
biochem
reaction
buffer
mm
nacl
mm
kcl
mm
mm
mm
dtt
black
micropl
fluoresc
intens
excit
emiss
well
observ
infinit
pro
plate
reader
tecan
inc
dub
activ
purifi
prrsv
assay
reaction
contain
indic
amount
purifi
protein
boston
biochem
polyubiquitin
chain
boston
biochem
reaction
buffer
mm
nacl
mm
kcl
mm
mm
mm
dtt
volum
ep
tube
mixtur
incub
h
subject
sdspage
analysi
trishcl
gel
cell
grown
confluenc
sixwel
plate
transfect
plasmid
encod
haubiquitin
deriv
either
singli
combin
via
lipofectamin
plu
invitrogen
ca
usa
h
posttransfect
cell
treat
selleck
h
collect
cell
wash
pb
twice
lyse
ripa
buffer
shaker
min
cell
lysat
subject
sdspage
western
blot
analys
antibodi
ha
myc
epitop
amount
actin
serv
load
control
transcleavag
assay
hek
cell
transfect
express
deriv
togeth
substrat
via
lipofectamin
plu
invitrogen
ca
usa
ciscleavag
assay
plasmid
code
deriv
transfect
singli
cell
h
posttransfect
express
enzym
subject
western
blot
analysi
use
cell
lysat
wherea
cleavag
substrat
analyz
immunoprecipit
coupl
western
blot
briefli
cell
rins
cold
pb
lyse
ripa
buffer
cell
debri
remov
centrifug
rpm
min
supernat
preclear
protein
ag
agaros
santa
cruz
ca
usa
shaker
min
clear
supernat
incub
antibodi
flag
epitop
ul
protein
ag
agaros
santa
cruz
ca
usa
overnight
immunocomplex
wash
thrice
cold
pb
protein
separ
sdspage
transfer
pvdf
membran
western
blot
analysi
membran
block
pbst
skim
milk
h
room
temperatur
incub
indic
primari
antibodi
antibodi
ha
epitop
overnight
wash
thrice
pbst
membran
incub
indic
secondari
antibodi
h
room
temperatur
wash
three
time
membran
develop
ecl
western
blot
analysi
system
mutagenesi
infecti
clone
hpprrsv
strain
mutat
first
introduc
shuttl
plasmid
peasyblunt
transgen
beij
china
contain
fragment
sitedirect
quikchang
mutagenesi
verif
sequenc
digest
fragment
transfer
infecti
clone
backbon
describ
previous
cell
grown
sixwel
plate
transfect
plasmid
either
wt
prrsv
mutant
virusinduc
cpe
monitor
daili
cell
cultur
harvest
day
posttransfect
cell
lysat
passag
blindli
onto
fresh
monolay
three
passag
viabil
mutant
determin
rtpcr
target
immunofluoresc
n
protein
rescu
virus
passag
titrat
cell
growth
kinet
analysi
cell
primari
pam
sixwel
plate
infect
mutant
parent
viru
moi
growth
cell
h
incub
cell
first
wash
acid
buffer
mm
nacl
mm
kcl
mm
citric
acid
ph
follow
rins
dmem
indic
time
point
infect
whole
cultur
harvest
freezethaw
three
time
releas
cellassoci
virus
sampl
titrat
cell
use
standard
endpoint
dilut
assay
accord
reedmuench
method
primari
pam
plate
infect
mutant
parent
viru
moi
h
postinfect
total
rna
extract
lysat
infect
pam
trizol
reagent
invitrogen
ca
usa
accord
manufactur
protocol
dissolv
rnase
free
water
concentr
rna
sampl
measur
nanodrop
lite
spectrophotomet
thermol
scientif
usa
total
rna
per
sampl
use
cdna
synthesi
fastquant
rt
kit
tiangen
beij
china
conduct
qpcr
assay
use
realtim
sybr
master
mix
kit
appli
biosystem
usa
realtim
pcr
system
appli
biosystem
usa
primari
pam
plate
infect
mutant
parent
viru
indic
moi
indic
time
point
postinfect
cell
cultur
supernat
quantifi
use
commerci
sandwich
enzymelink
immunosorb
assay
elisa
accord
manufactur
protocol
cusabio
wuhan
china
itass
onlin
servic
tool
use
model
structur
prrsv
strain
structur
refer
eav
interact
ubiquitin
analyz
pymol
coot
softwar
vitro
cleavag
effici
polyubiquitin
chain
express
ratio
amount
ub
plu
total
ub
measur
band
densiti
lanc
sdspage
imag
ratio
calcul
band
densiti
rel
dub
activ
mutant
measur
correspond
band
densiti
polyubiquitin
conjug
normal
actin
express
level
data
shown
sem
independ
experi
statist
signific
evalu
use
twoway
analysi
varianc
anova
statist
analys
perform
use
graphpad
prism
softwar
version
quantit
protein
band
measur
imag
j
softwar
version
ntermin
residu
prrsv
recent
report
exhibit
dub
activ
express
purifi
e
coli
cell
fragment
howev
express
low
level
hand
prevent
effici
purif
sinc
downstream
flank
sequenc
aa
critic
prrsv
function
infect
hypothes
region
might
critic
fold
domain
ctermin
extens
might
improv
solubl
yield
accordingli
made
two
addit
construct
includ
prrsv
strain
region
aa
aa
figur
protein
tag
strep
ii
epitop
tag
cterminu
facilit
purif
express
e
coli
cell
strep
ii
mostli
exist
pellet
prevent
effici
affin
purif
larg
scale
figur
lane
contrast
strepii
well
express
substanti
amount
present
supernat
figur
lane
moreov
fragment
sonic
supernat
could
subsequ
purifi
homogen
onestep
affin
purif
figur
lane
yield
mg
per
ml
cultur
thu
success
develop
strategi
realiz
highlevel
solubl
express
prrsv
dub
activ
purifi
subsequ
investig
seri
vitro
assay
first
test
abil
hydrolyz
ubamc
ubiquitin
conjug
aminomethylcoumarin
fluorophor
amc
monitor
releas
amc
dub
activ
measur
shown
figur
purifi
exhibit
dub
properti
vitro
better
activ
achiev
higher
concentr
next
examin
cleavag
specif
type
polyubiquitin
chain
figur
c
overal
total
amount
process
ub
monom
dimer
calcul
prrsv
exhibit
similar
effici
cleav
polyubiquitin
chain
cleavag
effici
figur
c
howev
prrsv
display
differenti
activ
convert
link
ubiquitin
dimer
monom
result
show
cleavag
monom
rel
ineffici
figur
reaction
take
place
dose
timedepend
manner
figur
exampl
lower
dose
mainli
cleav
ub
dimer
figur
lane
even
incub
time
extend
two
hour
figur
lane
howev
dose
increas
could
hydrolyz
effici
monom
within
h
figur
lane
differ
kinet
toward
cleav
versu
investig
detail
timedepend
manner
min
concentr
result
show
abl
quickli
cleav
within
minut
figur
e
convers
ubiquitin
dimer
monom
sever
fold
faster
dub
activ
figur
identifi
critic
residu
potenti
import
dub
activ
model
structur
core
domain
onlin
program
itass
use
eav
pdb
id
model
homolog
remodel
reveal
prrsv
strain
aa
overal
similar
structur
counterpart
eav
except
two
minor
structur
differ
indic
red
arrow
figur
bioinformat
analysi
also
identifi
acid
cluster
potenti
contact
posit
charg
cterminu
ubiquitin
figur
particular
ub
residu
form
posit
charg
surfac
wherea
prrsv
residu
form
neg
charg
region
model
show
charg
cterminu
insert
grove
form
neg
charg
residu
figur
closer
look
contact
site
reveal
potenti
interact
respect
potenti
hydrogen
bond
electrostat
interact
figur
contrast
posit
far
away
ub
cterminu
figur
identifi
acid
cluster
residu
highli
conserv
among
variou
prrsv
strain
wherea
residu
highli
conserv
among
type
ii
prrsv
strain
replac
respect
residu
type
prrsv
strain
figur
among
residu
shown
critic
transcleavag
thu
therefor
select
residu
mutat
analysi
purpos
distinguish
dub
transcleavag
activ
acid
residu
chang
either
residu
asparagin
n
opposit
charg
residu
arginin
r
wherea
replac
either
serin
glycin
g
arginin
r
correspond
mutant
express
purifi
e
coli
cell
enzymat
activ
test
vitro
dub
assay
figur
quantifi
rel
activ
shown
right
correspond
figur
result
show
mutat
residu
eg
etc
much
effect
dub
activ
correspond
mutant
could
effici
cleav
polyubiquitin
chain
monom
figur
lane
contrast
mutat
residu
either
n
r
larg
block
cleavag
small
portion
cleav
ub
dimer
monom
figur
lane
mutat
effect
amino
aciddepend
mutat
larg
block
dub
activ
figur
lane
wherea
mutat
affect
cleavag
much
figur
lane
residu
substitut
r
larg
ablat
dub
activ
figur
lane
wherea
mutat
serin
effect
figur
lane
mutat
larg
effect
abil
process
polyubiquitin
chain
figur
lane
bottom
panel
partial
crippl
abil
cleav
ubiquitin
dimer
figur
lane
top
panel
suggest
differenti
sensit
next
use
cellbas
assay
check
mutat
effect
dub
activ
within
mammalian
cell
figur
time
mutant
figur
lane
shown
defect
transcleavag
activ
use
neg
control
hatag
ubiquitin
transient
express
hek
cell
togeth
mutant
h
posttransfect
cell
lysat
collect
assess
level
ubiquitin
western
blot
analysi
antibodi
ha
epitop
figur
result
show
mutant
dub
activ
figur
contrast
mutant
lost
dub
activ
togeth
control
mutant
figur
hand
mutat
partial
crippl
dub
activ
figur
lane
overal
cellbas
result
larg
consist
vitro
dub
assay
addit
result
mutagenesi
studi
accord
bioinformat
predict
except
sever
mutat
eg
discuss
discuss
section
next
investig
whether
mutat
affect
ci
transcleavag
activ
import
process
prrsv
polyprotein
infect
address
question
perform
cellbas
assay
coexpress
deriv
substrat
lack
domain
transfect
cell
figur
neg
substrat
control
cleavag
site
junction
mutat
make
construct
figur
shown
figur
except
control
mutant
capabl
effici
process
polyprotein
suggest
mutat
affect
transcleavag
activ
thu
mutat
eg
etc
affect
dub
activ
use
differenti
dub
activ
transcleavag
activ
next
investig
whether
mutat
affect
ciscleavag
activ
sinc
ciscleavag
essenti
intramolecular
interact
mutat
effect
evalu
use
fulllength
polyprotein
precursor
report
previous
addit
sinc
ci
transcleavag
activ
direct
cleavag
transcleavag
silenc
first
place
proceed
test
effect
cisact
took
advantag
mutat
abl
decoupl
ci
transcleavag
activ
use
prrsv
strain
consist
mutat
strongli
reduc
transcleavag
activ
process
tran
cotransfect
assay
figur
lane
cleavag
effici
make
sure
fulllength
carri
mutat
also
behav
seen
fragment
figur
lane
introduc
mutat
fulllength
prrsv
strain
expect
fulllength
carri
mutat
also
fail
process
tran
polyprotein
lack
proteas
domain
cotransfect
cell
figur
lane
suggest
transcleavag
activ
block
mutat
introduc
precursor
howev
affect
process
ci
figur
lane
thu
result
agreement
previou
report
base
prrsv
strain
next
introduc
correspond
acid
cluster
point
mutat
background
figur
allow
cisprocess
surpris
mutat
eg
larg
ablat
dub
activ
also
block
cisact
figur
lane
respect
contrast
neither
affect
ciscleavag
activ
figur
lane
notabl
mutat
could
select
block
ciscleavag
activ
figur
lane
mutant
still
equip
transcleavag
activ
figur
lane
larg
dub
activ
figur
lane
togeth
result
suggest
requir
dub
activ
somehow
close
relat
ciscleavag
activ
rather
transcleavag
activ
addit
critic
mutat
differenti
ciscleavag
activ
dub
transcleavag
activ
mutat
effect
viral
replic
test
introduc
correspond
point
mutat
infecti
cdna
clone
hpprrsv
strain
dnalaunch
system
recombin
plasmid
transfect
cell
viru
recoveri
analys
revers
genet
mutant
led
find
follow
tabl
mutat
larg
block
dub
activ
cellbas
assay
lethal
viru
ii
mutat
effect
dub
activ
affect
viral
viabil
iii
point
mutat
select
block
cisact
affect
viral
viabil
cell
cultur
iv
mutat
affect
either
activ
somehow
allow
rescu
viabl
viru
togeth
result
strongli
suggest
dispens
role
cisact
prrsv
viabil
hand
fact
ciscleavag
activ
requir
prrsv
replic
suggest
lethal
phenotyp
sever
point
mutat
block
dub
cisact
due
block
ciscleavag
activ
may
link
inactiv
dub
activ
four
viabl
mutant
passag
chosen
growth
kinet
analysi
cell
figur
primari
pam
figur
mutant
test
show
rel
similar
growth
properti
parent
viru
except
mutant
exhibit
reduc
growth
cell
half
log
slight
decreas
pam
although
statist
insignific
figur
test
stabil
sequenc
mutat
region
end
experi
virus
result
show
mutat
stabl
figur
addit
see
compens
mutat
aris
within
sinc
prrsv
involv
antagon
host
innat
immun
mutant
appar
growth
defect
primari
pam
test
whether
mutat
effect
inflammatori
cytokin
product
rather
interferon
signal
particular
focus
express
secret
figur
potent
inflammatori
cytokin
end
primari
pam
infect
wt
mutant
virus
moi
h
postinfect
mrna
level
measur
rel
quantit
rtpcr
normal
peptidylprolyl
isomeras
ppia
molecul
previous
use
intern
control
result
show
prrsv
strain
significantli
upregul
mrna
express
figur
hand
effect
impress
figur
interestingli
mutant
exhibit
greatli
reduc
abil
induc
express
lesser
extent
mutant
figur
similarli
none
mutant
affect
level
figur
also
measur
secret
cytokin
infect
supernat
elisa
consist
reduct
mrna
level
observ
signific
drop
cell
cultur
supernat
primari
pam
infect
mutant
figur
tri
sever
commerci
kit
unfortun
work
well
hand
test
whether
effect
conting
infect
dose
chose
analysi
figur
result
show
either
moi
could
significantli
reduc
secret
infect
supernat
figur
compar
wt
reduct
mutant
h
postinfect
later
moreov
mutant
greater
abil
reduc
product
figur
final
evalu
whether
observ
effect
proinflammatori
cytokin
product
associ
alter
dub
activ
introduc
correspond
mutat
fulllength
rather
mere
fragment
figur
deubiquitin
abil
deriv
test
transfect
cell
coexpress
haubiquitin
consist
phenotyp
exhibit
truncat
mutant
figur
lane
behav
like
wt
figur
lane
larg
dubact
figur
lane
contrast
catalyt
site
mutat
block
dub
activ
fulllength
figur
lane
togeth
data
provid
strong
evid
critic
role
prrsv
induc
infect
also
properti
independ
dub
activ
known
prrsv
possess
least
ci
transcleavag
dub
activ
transact
requir
region
aa
report
went
much
reveal
sever
import
biolog
aspect
particular
proteas
begin
vitro
purif
found
downstream
flank
sequenc
aa
critic
yield
solubl
domain
prokaryot
express
system
figur
although
previou
studi
report
prrsv
strain
aa
suffici
dub
activ
vitro
provid
descript
express
level
purif
fragment
hand
fragment
unfortun
poorli
express
e
coli
cell
despit
attempt
optim
express
condit
although
truncat
usual
way
protein
express
use
unconvent
approach
solv
problem
make
ctermin
extens
dramat
improv
yield
solubl
figur
result
suggest
flank
sequenc
like
play
import
role
fold
core
domain
consist
previou
find
delet
aa
lethal
prrsv
strain
realiz
highlevel
solubl
express
also
pave
way
futur
structur
studi
vitro
drug
screen
previou
studi
shown
prrsv
possess
differenti
dub
activ
toward
cleav
ubiquitin
dimer
monom
result
gener
agreement
find
differ
previou
studi
found
prrsv
abl
cleav
ubiquitin
dimer
dose
timedepend
manner
differ
like
attribut
flank
sequenc
aa
figur
promot
fold
core
domain
lead
increas
cleavag
effici
toward
polyubiquitin
chain
addit
found
prrsv
strain
equal
effici
cleav
dimer
monom
also
identifi
critic
residu
prrsv
dub
activ
amino
acid
highli
conserv
among
prrsv
strain
reveal
key
residu
prrsv
dub
activ
figur
either
conserv
nonconserv
substitut
led
signific
destruct
dub
activ
figur
mutat
effect
also
appear
specif
similar
mutat
nearbi
residu
also
highli
conserv
effect
figur
result
also
accord
bioinformat
predict
figur
mutat
effect
residu
conting
amino
acid
use
substitut
exampl
mutat
larg
block
activ
partial
block
dub
activ
figur
suspect
mutat
effect
like
indirect
could
result
electrostat
interact
chang
local
structur
similar
manner
mutat
potenti
interact
local
lead
local
conform
chang
may
advers
effect
function
also
partial
explain
effect
interestingli
found
mutat
select
block
ciscleavag
activ
figur
without
affect
transcleavag
activ
figur
partial
block
dub
activ
either
truncat
figur
fulllength
form
figur
first
time
report
point
mutat
distinguish
ciscleavag
activ
pave
way
test
import
ciscleavag
activ
prrsv
infect
view
hydrolysi
ubiquitin
substrat
take
advantag
transact
viral
dub
surprisingli
observ
intrigu
relationship
prrsv
dub
cisact
sever
mutat
larg
block
dub
activ
found
also
ablat
cisact
includ
mutant
figur
figur
contrast
none
mutat
effect
transact
cleav
polyprotein
figur
thu
seem
requir
prrsv
dub
activ
somehow
close
relat
cisact
suggest
may
share
intrins
common
mechanist
detail
term
recognit
cleavag
substrat
knowledg
first
report
reveal
intim
relationship
dub
cisact
concern
otu
cystein
proteas
molecular
basi
observ
current
clear
hope
elucid
threedimension
structur
prrsv
may
help
resolv
puzzl
futur
longask
question
whether
dub
ciscleavag
activ
essenti
prrsv
infect
inabl
differenti
enzymat
activ
point
mutat
limit
evalu
contribut
individu
enzymat
activ
despit
report
sever
studi
dub
activ
none
establish
strong
correl
dub
viral
replic
rule
mutat
effect
tran
ciscleavag
activ
take
advantag
sitedirect
mutagenesi
first
place
provid
strong
evid
suggest
cisact
necessari
viral
replic
figur
evidenc
specif
point
mutat
select
block
ciscleavag
activ
allow
success
rescu
viabl
viru
moreov
mutant
exhibit
similar
growth
rate
wt
primari
pam
figur
contrast
mutat
eg
etc
larg
disarm
dub
activ
lethal
prrsv
cell
although
mutat
also
crippl
ciscleavag
activ
time
success
rescu
mutant
strongli
argu
essenti
contribut
inact
cisact
nonviabl
phenotyp
addit
lethal
phenotyp
less
like
due
potenti
defect
deisgyl
activ
report
hpprrsv
strain
use
studi
limit
deisgyl
activ
isgyl
observ
prrsvinfect
cell
cell
line
use
viru
rescu
thu
appear
exist
strong
correl
lethal
phenotyp
mutat
essenti
role
dub
activ
prrsv
infect
sun
et
al
recent
character
otu
domain
european
prrsv
strain
type
strain
report
inhibit
activ
dub
activ
also
mutat
residu
acid
cluster
includ
residu
etc
correspond
residu
studi
respect
consist
studi
mutat
lethal
prrsv
wherea
allow
success
rescu
viabl
viru
studi
mutant
affect
viral
growth
wherea
crippl
viru
cell
sun
et
al
correl
growth
properti
abil
inhibit
activ
found
mutat
lethal
viru
capabl
complet
inhibit
activ
wherea
mutat
unabl
inhibit
activ
wt
lead
viabl
viru
howev
test
mutat
effect
mutant
ci
transcleavag
activ
dub
activ
studi
suggest
lethal
phenotyp
link
impair
ci
transcleavag
activ
rather
relat
effect
dub
activ
howev
neg
result
could
rule
possibl
dubinactiv
mutat
may
unexpect
consequ
render
viru
nonviabl
hand
mutat
affect
much
dub
activ
allow
rescu
viabl
virus
result
suggest
mutat
may
advers
effect
function
highlight
complex
mutat
effect
function
anoth
interest
observ
partial
ablat
dub
activ
affect
viral
viabil
wherea
nearcomplet
block
eg
etc
lethal
viru
result
may
suggest
exist
threshold
dub
activ
requir
prrsv
replic
dub
activ
may
requir
remov
polyubiquitin
substrat
futur
studi
direct
investig
detail
mechan
prrsv
play
infect
infect
prrsv
often
caus
deregul
inflammatori
cytokin
product
chines
hpprrsv
inhibit
inflamm
earli
infect
induc
inflammatori
storm
late
stage
pig
contribut
lung
injuri
interstiti
pneumonia
regulatori
mechan
process
remain
poorli
understood
known
sever
nonstructur
protein
includ
capabl
inhibit
inflamm
respons
wherea
structur
protein
n
e
promot
inflamm
prrsv
type
interferon
signal
antagonist
recent
implic
modul
proinflammatori
cytokin
product
infect
liu
et
al
report
mutant
hpprrsv
strain
bb
carri
delet
region
aa
aa
reduc
abil
induc
express
inflammatori
cytokin
pam
howev
correspond
mutant
also
exhibit
reduc
growth
titer
log
compar
parent
viru
moreov
downregul
quit
subtl
hand
singlesit
substitut
repres
nice
approach
minim
risk
gross
conform
alter
result
mutagenesi
begin
studi
mean
studi
role
inflammatori
cytokin
induct
two
independ
pointmut
mutant
hand
unexpectedli
establish
strong
link
prrsvinduc
induct
proinflammatori
cytokin
figur
figur
mutant
retain
similar
growth
rate
parent
viru
primari
pam
exhibit
significantli
reduc
abil
induc
mrna
protein
level
figur
figur
moreov
reduct
rate
hpi
later
figur
suggest
decis
role
modul
product
infect
differ
previou
studi
observ
chang
express
level
crippl
abil
induc
attribut
impair
dub
activ
mutant
fulli
dub
activ
figur
addit
viral
dub
often
neg
regul
host
innat
immun
expect
inactiv
dub
activ
promot
inflammatori
cytokin
product
report
sever
case
result
howev
show
opposit
mutant
partial
crippl
dub
activ
show
reduc
product
figur
figur
thu
two
independ
mutant
show
similar
phenotyp
result
provid
strong
evid
suggest
dubindepend
regulatori
mechan
prrsv
induc
product
togeth
find
deepen
understand
biolog
properti
function
prrsv
also
provid
clue
pathogen
mechan
hpprrsv
addit
result
implic
vaccin
develop
modifi
reduc
cytokineinduc
lung
injuri
near
futur
interest
address
molecular
mechan
point
mutat
lead
crippl
abil
prrsv
induc
proinflammatori
cytokin
